acrolein has been researched along with Carcinoma, Transitional Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Chiang, CH; Chow, PM; Hong, JH; Huang, CY; Jaw, FS; Lee, PAH; Liu, JH; Lu, YC; Wang, CC; Wang, HT; Wang, TW | 1 |
| Cannon, J; Cos, LR; Linke, CA | 1 |
| Levine, LA; Richie, JP | 1 |
1 review(s) available for acrolein and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Urological complications of cyclophosphamide.
Topics: Acrolein; Adult; Carcinoma, Transitional Cell; Child; Cyclophosphamide; Cystitis; Dose-Response Relationship, Drug; Humans; Urinary Bladder Neoplasms; Urination Disorders | 1989 |
2 other study(ies) available for acrolein and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Acrolein contributes to urothelial carcinomas in patients with chronic kidney disease.
Topics: Acrolein; Aged; Carcinoma, Transitional Cell; DNA Damage; Female; Genes, p53; Humans; Male; Middle Aged; Mutation; Renal Insufficiency, Chronic; Tumor Cells, Cultured; Urologic Neoplasms | 2020 |
Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention.
Topics: Acrolein; Adult; Carcinoma, Transitional Cell; Cyclophosphamide; Epithelium; Female; Humans; Male; Middle Aged; Urinary Bladder Neoplasms | 1991 |